GlassScriptPhysician profile
Caroline C Mignacca
NPI 1861849572
$2,066.75
in general payments reported to CMS, 2019-2025
28 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $311 · 2021: $460 · 2022: $214 · 2023: $498 · 2024: $292 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.12 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $369.78 | 2020-2025 | Aptima, Affirm Prone Biopsy System |
| Abbvie INC. | $357.10 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $164.59 | 2021-2023 | |
| Astellas Pharma US INC | $157.36 | 2023 | Veozah |
| Coopersurgical, INC. | $130.28 | 2020-2024 | Paragard T 380a, Paragard T 380a |
| Amniox Medical, INC. | $107.20 | 2019 | |
| Aspira Women'S Health INC | $91.04 | 2020 | |
| Millicent US INC | $79.07 | 2024 | Intrarosa, Femring |
| Avion Pharmaceuticals | $56.13 | 2021-2023 | Balcoltra |
| Daiichi Sankyo INC. | $53.28 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.83 | 2020-2023 | |
| Organon LLC | $46.52 | 2021-2022 | |
| Ge Healthcare | $44.67 | 2025 | |
| Therapeuticsmd, INC. | $42.84 | 2021-2022 | |
| Evofem Biosciences, INC. | $38.88 | 2021-2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $36.03 | 2023-2024 | Cologuard Collection Kit |
| Shield Therapeutics INC | $32.60 | 2023-2024 | Accrufer |
| Mission Pharmacal Company | $28.65 | 2023 | |
| Optumhealth Care Solutions, LLC | $27.48 | 2023 | Vivify Health Care Team Portal |
| Lupin INC. | $24.55 | 2020 | |
| Smith+Nephew, INC. | $22.76 | 2022 | |
| Pfizer INC. | $21.99 | 2024 | |
| Axonics, INC. | $20.63 | 2023 | Axonics |
| Exeltis, USA INC. | $13.78 | 2023 | Slynd |
| Conmed Corporation | $13.47 | 2019 | |
| Scynexis, INC. | $13.13 | 2022 | |
| Heron Therapeutics, INC. | $12.25 | 2019 | |
| Myovant Sciences INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Mignacca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.